Médecins Sans Frontières

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment

120,707 people signed petitions urging the corporation to drop the price.

Read More →

World TB Day 2020: As coronavirus spreads, preventing and treating TB must remain a priority

As the world grapples with the global pandemic of coronavirus, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide, like people with tuberculosis (TB), whose lungs are often damaged and immune systems weakened.

Read More →

MSF technical briefs

Médecins Sans Frontières (MSF) updated two of its technical briefs, A rapid TB test for people living with HIV and Making the switch.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs - webinar materials now available online

Treatment Action Group, Médecins Sans Frontières and Health GAP conducted a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs

Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5

The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.

Read More →

TB activists disrupt opening of The Union Conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. 

Read More →

Price announced for new lifesaving TB drug pretomanid still too high

Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.

Read More →

Global campaign launched urging Johnson & Johnson to reduce price of bedaquiline

Médecins Sans Frontières launches a global campaign calling on Johnson & Johnson to lower the price of bedaquiline to no more than US$1 per day.

Read More →

Page 1 of 7 · Total posts: 10

1 2 Last→